Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Adapthealth Corp is a medical devices business based in the US. Adapthealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. Adapthealth employs 10,700 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $18.17 |
|---|---|
| 52-week range | $11.40 - $28.75 |
| 50-day moving average | $16.38 |
| 200-day moving average | $19.51 |
| Wall St. target price | $24.10 |
| PE ratio | 22.4321 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.81 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $18.17 from 2022-07-01
| 1 week (2022-06-27) | -5.71% |
|---|---|
| 1 month (2022-06-02) | -0.06% |
| 3 months (2022-03-31) | N/A |
| 6 months (2022-01-04) | -21.98% |
| 1 year (2021-07-02) | -33.81% |
|---|---|
| 2 years (2020-07-02) | -9.15% |
| 3 years (2019-07-03) | 80.08% |
| 5 years (2017-06-30) | N/A |
Valuing Adapthealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adapthealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Adapthealth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Adapthealth shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Adapthealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $573.3 million.
The EBITDA is a measure of a Adapthealth's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.7 billion |
|---|---|
| Operating margin TTM | 10.61% |
| Gross profit TTM | $528 million |
| Return on assets TTM | 3.67% |
| Return on equity TTM | 10.43% |
| Profit margin | 7.51% |
| Book value | $15.76 |
| Market capitalisation | $2.4 billion |
TTM: trailing 12 months
We're not expecting Adapthealth to pay a dividend over the next 12 months.
Over the last 12 months, Adapthealth's shares have ranged in value from as little as $11.4 up to $28.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adapthealth's is 0.5714. This would suggest that Adapthealth's shares are less volatile than average (for this exchange).
AdaptHealth Corp. , together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.